Conference
Assessment of changes in patient function, measured by the health assessment questionnaire - Disability index (HAQ-DI), following daily subcutaneous (SC) injections of kineret (TM) (anakinra-recombinant interleukin-1 receptor antagonist) in a standard practice population of patents with rheumatoid arthritis (RA)
Authors
Cividino A; Russell A; Offer R; Pirc L; Choquette D
Volume
30
Pagination
pp. 1878-1878
Publisher
J RHEUMATOL PUBL CO
Publication Date
August 1, 2003
Name of conference
Annual Meeting of the Canadian-Rheumatology-Association
Conference place
LAKE LOUISE, CANADA
Conference start date
February 23, 2003
Conference proceedings
JOURNAL OF RHEUMATOLOGY
Issue
8
ISSN
0315-162X